Anna G. Syrkina

Anna G. Syrkina

Auto-generated profile, based on publicly available information

Anna G. Syrkina

Cardiology Research Institute, Tomsk National Research Medical Center

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VRVyacheslav Ryabov
Vyacheslav Ryabov
ASA. G. Syrkina
A. G. Syrkina
NBN. V. Belokopytova
N. V. Belokopytova
VMV. A. Markov
V. A. Markov
AEA. D. Erlikh
A. D. Erlikh
ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ С ПОДЪЕМОМ СЕГМЕНТА ST У ПАЦИЕНТОВ С НЕОБСТРУКТИВНЫМ ПОРАЖЕНИЕМ КОРОНАРНОГО РУСЛА: ДАННЫЕ РЕГИСТРА РЕКОРД-3

17 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VRVyacheslav Ryabov
Vyacheslav Ryabov
OPOleg Panteleev
Oleg Panteleev
MKMaria Kercheva
Maria Kercheva
AGAlexei A. Gorokhovsky
Alexei A. Gorokhovsky
ASAnna G. Syrkina
Anna G. Syrkina
NMNatalia Y. Margolis
Natalia Y. Margolis
Aim: To access the features of the course of myocardial infarction (MI) in patients with different stages of MI complicated by cardiogenic shock (MI CS) according to the SCAI scale. Methods: We retrospectively described the portrait of CS MI (n = 117) at different stages of SCAI from the hospital MI registry (n = 1253). Results: Hospital mortality increased from stage to stage (p ≤ 0.001). Significant differences in biochemical parameters were found both for indicators characterizing intensive care measures, such as the presence of mechanical lung ventilation or an intra-aortic balloon pump, and for indicators of organ hypoperfusion such as lactate level, pHv (7.39 (7.36; 7.44) at stage A–B; 7.14 (7.06; 7.18) at stage E), creatinine, and glomerular filtration rate. Parameters related to MI characteristics, such as instrumental and laboratory data, anamnesis of ischemia, and performed treatment, did not differ between groups. Polynomial logistic regression showed that lactate level, mechanical ventilation, and monocyte count upon admission (1.15 (0.96; 1.23) at stage A–B; 0.78 (0.49; 0.94) at stage E, p = 0.005) correlated with CS severity. Conclusion: The characteristics of MI at different stages of SCAI do not have differences and do not determine the severity of shock. We revealed a high discriminatory potential of the pH level in predicting refractory shock. The value of monocytes at admission may be a promising predictor of the severity of MI CS. The question of the causes of heterogeneity of MI CS, taking into account the homogeneity of MI characteristics, remains open and promising.

8 March 2019 in Kardiologiia
Verified
Journal Article
Open access
PDF file
EVE. V. Vyshlov
E. V. Vyshlov
AKA. L. Krylov
A. L. Krylov
ASA. G. Syrkina
A. G. Syrkina
YAY. V. Alexeeva
Y. V. Alexeeva
SDS. V. Demyanov
S. V. Demyanov
VRV. V. Ryabov
V. V. Ryabov
Aim: to investigate safety and angiographic efficacy of two-stage revascularization with percutaneous coronary intervention (PCI) with stenting delayed by one day in patients with acute myocardial infarction (MI) and massive coronary thrombosis. Materials and methods. We included in this study 12 patients with massive infarct related coronary artery thrombus which length was greater than thrice the vessel diameter in the presence of TIMI grade II–III blood flow as detected by coronary angiography (CAG). The emergency PCI was not performed, and conservative antithrombotic therapy continued for 24 hours. After this day, CAG was repeated. Results. Repeat CAG in all patients showed thrombus regression which visually appeared as complete lysis in 8, and partial lysis – in 4 patients. Stenting of residual stenosis was performed in 11 patients without complications. In 1 patient residual stenosis was considered insignificant (<50 %) therefore stenting was not performed. No-reflowphenomenon and recurrent MI were not observed. Conclusion. These data suggest that in patients with massive coronary artery thrombosis conservative antithrombotic therapy for 24 hours followed by repeated CAG and, if required, by stenting of residual stenosis, is safe treatment tactics that might reduce the risk of the no-reflow phenomenon.

25 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
VRVyacheslav Ryabov
Vyacheslav Ryabov
Trusov AndreyTrusov Andrey
Trusov Andrey
MKMaria Kercheva
Maria Kercheva
AGAleksandra Gombozhapova
Aleksandra Gombozhapova
JIJulia Ilyushenkova
Julia Ilyushenkova
SSSvetlana Ivanovna Sazonova
Svetlana Ivanovna Sazonova
Nuclear imaging modalities can detect somatostatin receptor type 2 (SSTR2) in vivo as a potential marker of local post-MI inflammation. SSTR2+ macrophages are thought to be the main substrate for SSTR-targeted radioimaging. However, the distribution of SSTR2+ cells in the MI patients’ myocardium is unknown. Using immunohistochemistry, we investigated the distribution of SSTR2+ cells in the myocardium of patients who died during the MI inflammatory phase (n = 7) compared to the control group of individuals with fatal trauma (n = 3). Inflammatory cellular landscapes evolve in a wave front-like pattern, so we divided the myocardium into histological zones: the infarct core (IC), the border zone (BZ), the remote zone (RZ), and the peri-scar zone (PSZ). The number of SSTR2+ neutrophils (NPs), SSTR2+ monocytes/macrophages (Mos/MPs), and SSTR2+ vessels were counted. In the myocardium of the control group, SSTR2+ NPs and SSTR2+ Mos/MPs were occasional, SSTR2+ vessels were absent. In the RZ, the picture was similar to the control group, but there was a lower number of SSTR2+ Mos/MPs in the RZ. In the PSZ, SSTR2+ vessel numbers were highest in the myocardium. In the IC, the median number of SSTR2+ NPs was 200 times higher compared to the RZ or control group myocardium, which may explain the selective uptake of SSTR-targeted radiotracers in the MI area during the inflammatory phase of MI.

11 November 2018 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
VRVyacheslav Ryabov
Vyacheslav Ryabov
SDS. K. Demianov
S. K. Demianov
ASA. G. Syrkina
A. G. Syrkina
NBN. V. Belokopitova
N. V. Belokopitova
EVE. V. Vyshlov
E. V. Vyshlov
RKR. S. Karpov
R. S. Karpov
According to the Russian registry RECORD, the hospital mortality at STEMI in domestic hospitals remains high, which is due to the low frequency of reperfusion measures. There are problems in treatment patients of senile age. Comparative studies of the quality of care for patients with acute coronary syndrome were not conducted in Russia. 489 patients with STEMI, arrived in the first 24 hours from the onset of MI were analyzed. Quality of care for patients with STEMI was evaluated according to the quality criteria of the Association of Emergency Cardiovascular Care of the European Society of Cardiology. To compare the quality of care for patients of different age groups, the endpoints were the frequency of use of TLT and primary PCI, the incidence of cardiogenic shock, pulmonary edema, acute left ventricular aneurysm, and acute psychotic disorders. It is shown that patients with STEMI receive emergency medical care of high quality in adequate time. Elderly STEMI patients are less likely to undergo percutaneous coronary intervention, have more extensive myocardial damage with severe left ventricular failure and acute psychotic disorders, which is associated with a multiple increase in hospital mortality. The most frequent reasons for rejecting PCI were acute mental disorders, multivessel diffuse lesions of the coronary arteries with pronounced calcinosis, small diameter of the artery. It is necessary to develop new devices or techniques for PCI in conditions of severe multivessel lesions of coronary arteries with pronounced calcification, and also develop methods of neuroprotection in order to overcome existing barriers in providing emergency high-tech medical care to elderly STEMI patients.

17 May 2018
Verified
Conference Paper
Closed access
PDF file
Yury V. KistenevYury V. Kistenev
Yury V. Kistenev
ASAnna G. Syrkina
Anna G. Syrkina
DKDmitry A. Kuzmin
Dmitry A. Kuzmin
ABAlexey V. Borisov
Alexey V. Borisov
Myocardial infarction (MI) causes partial or complete necrosis of the heart muscle. It means that muscle cells are wiped, and the contractility of the heart decreases. Today, for the MI diagnosis is based on the ECG recording or specific biomarkers identifying in the patient's blood, the most specific of which are: creatine phosphokinase (CPK), CPK-MB, fatty acids binding protein (H-FABP), myoglobin troponin-I, and troponin-T. Additionally to these biomarkers in the MI patients’ blood, there are many other products of metabolism in damaged muscles, which are excreted from the body human body, including through exhaled air. The results of MI patients’ exhaled air analysis using photoacoustic laser spectroscopy and data mining are presented.